NCT01609712

Brief Summary

Patients with vertebral fractures often have problems to straighten and as a consequence of impaired lung ventilation that leads to a impaired lung function. Furthermore, it comes to the sintering of the vertebra and a so-called hunchback. This also contributes to the poorer expansion of the lung. Pain is also caused by respiratory excursions of the chest which hinder the patients to use their entire lung volume. Kyphoplasty is designed to counter all these consequences of vertebral fractures by bringing stability to the fracture. In order to prove the thesis the results of lung function test (FEV1, PEF) are assessed.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

May 29, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 1, 2012

Completed
Last Updated

June 5, 2012

Status Verified

June 1, 2012

First QC Date

May 29, 2012

Last Update Submit

June 3, 2012

Conditions

Keywords

Improvement of lung function (FEV1, PEF)Visual Analog ScaleOswestry Disability IndexRadiographs pre and post Op

Study Arms (1)

Patient with vertebral compression fracture

RF kyphoplasty is standard of care in our hospital for patients with osteoporortic compression fractures. We are intersetd, if it also can improve the lung function.

Procedure: Radiofrequency Kyphoplasty

Interventions

Radiofrequency kyphoplasty is a new form of surgical treatment. It injects an ultrahigh viscosity cement into the fractured vertebral body, using radiofrequency to achieve the proper consistency of the cement. This ultrahigh viscosity cement is designed to first restore proper height and alignment to the fractured vertebra and then to stabilize the fracture, thereby preventing further intravertebral motion and reducing pain. The RF-Kyphoplasty is standard of care in our hospital. It is FDA and CE approved.

Also known as: RF-Kyphoplasty
Patient with vertebral compression fracture

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with osteoporotic compression fractures, mostly elderly females

You may qualify if:

  • over 50 years
  • VAS over 49, ODI over 29
  • radiographic evidence of A 1.1, 1.2, 1.3 fractures
  • patients mentally capable to sign informed consent

You may not qualify if:

  • high-energy trauma
  • known tumor involvement
  • osteonecrotic fractures
  • burst fractures or pedicle fractures
  • previous surgical treatment for a vertebral body compression fracture
  • patient has paget's disease
  • BMI \> 35
  • uncontrolled diabetes HbAc1c \> 7%
  • severe cardiopulmonary disease
  • Myelopathy
  • long-time steroid therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthopädie und Unfallchirurgie Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, 53127, Germany

RECRUITING

Study Officials

  • Robert Pflugmacher, M.D.

    Orthopädie und Unfallchirurgie, Universitätsklinkum Bonn

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD Dr. med.

Study Record Dates

First Submitted

May 29, 2012

First Posted

June 1, 2012

Study Start

May 1, 2012

Last Updated

June 5, 2012

Record last verified: 2012-06

Locations